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The aim of this study was to define the neurohumoral response associated with the 
renal hemodynamic perturbations induced by mental stress acting as an adrener- 
gic stimulus. In 8 healthy women, the effects of mental stress were studied during 
four consecutive 30-minute periods (baseline, mental stress, recovery I, recovery II). 
Mental stress induced sympathetic activation as evidenced by increases in blood 
pressure, heart rate, and plasma norepinephrine level. Effective renal plasma flow 
(iodine 131-1abeled hippurate clearance) decreased only during mental stress 
(-22%, p < 0.05 vs baseline); glomerular filtration rate (iodine 125-1abeled iota- 
lamate clearance) remained constant during the entire experiment; the filtration 
fraction increased significantly during mental stress and recovery I (+30% and 
+22%, respectively, p < 0.02 for both). Complex neuroendocrine responses were 
associated with the hemodynamic changes. Urinary excretion of endothelin- I and 
6-keto-PGF1~ increased during mental stress (+53%, p < 0.01, and +20%, p < 0.01, 
respectively) and recovery I (+49% and +29%, respectively, p < 0.01 for both). 
Urinary cyclic guanosine monophosphate rose only during mental stress (+ 77%, p < 
0.05), whereas excretion of PGE2 showed a stepwise increase throughout recovery 
I and II (+292%, p < 0.01, and +360%, p < 0.001, respectively), in conclusion, the 
present experiments demonstrate that renal hemodynamic response induced by 
mental stress is a complex reaction in which endothelin-1, prostaglandins, and 
presumably nitric oxide take part. (J Lab Clin Med 1997; 129:462-9) 
Abbreviations: ANF = atrial natriuretic factor; ANOVA = analysis of variance; cGMP = cyclic 
guanosine monophosphate; EDTA = ethylenediaminetetraacetic a id; ERPF = effective renal 
plasma flow; HR = heart rate; GFR = giomerular filtration rate; PRA = plasma renin activity; 
UPGE2 = urinary prostaglandin E2, UPGF2= = urinary prostaglandin F2=: UTXB2 = urinary throm- 
boxane B2; U6-keto-PGFl= = urinary 6-keto-prostaglandin FI= 
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T he kidney adapts to stimulation of the sympa- thetic nervous system with a complex reaction that keeps GFR constant. 1'2 An important 
part of this reaction is the activation of a wide array 
of  neurohumoral  systems, the roles of which are not 
fully understood, particularly in terms of an inte- 
grated response. The renin-angiotensin and adren- 
ergic nervous systems and renal eicosanoids are 
known to be involved. 3-6 However, the role of  newly 
discovered substances such as endothelins and nitric 
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xide in the response of the human kidney to stressful 
stimuli has not been defined. Endothelin is abundantly 
synthesized by the endothelial and mesangial cells of 
the kidney 7 and causes a sustained and prolonged 
renal vasoconstriction a d a marked decrease in glo- 
merular filtration rate. s Endothelin also interacts with 
the three systems enumerated above: it can be re- 
leased by both angiotensin II and adrenergic stimula- 
tion 7'9'1° and, in turn, endothelin stimulates renal 
eicosanoid release in in vitro and animal experi- 
ments. 11'12 In addition, endothelin has been reported 
to promote the formation of nitric oxide in the kid- 
ney. 13 
Both animal and human studies 14'~5 have shown 
that adrenergic stimulation may lead to a sharp 
decline in renal blood supply. This decline may be 
aggravated to the point of causing acute renal fail- 
ure when it is associated with an underlying renal 
disease a6 or when there is a derangement of the 
neurohumoral systems, such as the inhibition of re- 
nal eicosanoids during nonsteroidal anti-inflamma- 
tory drug administration. 17'a8 
To have some understanding of the possible 
mechanisms of this shift from vasoconstriction to
ischemic damage or renal failure, it is mandatory to 
first fully understand the physiologic renal response 
to adrenergic stimulation in its integrated setting of 
hormonal reactions. 
Therefore, the aim of the present study was to 
examine, in healthy human subjects, the neurohu- 
moral response that parallels renal hemodynamic 
adjustments evoked by adrenergic stimulation as 
induced by a well-defined mental stress. In par- 
ticular, the "classical" vasoactive systems (namely 
plasma renin activity, catecholamine, and prosta- 
glandins) and the changes in time in endothelin and 
cGMP as an index of nitric oxide/atrial natriuretic 
factor activation were evaluated. ~9-21 
METHODS 
Subjects. Experiments were carried out in 8 healthy 
nonpregnant female volunteers who were 24 to 40 years of 
age (mean _+ SD, 31 -+ 6) and who had given their 
informed consent o participate in the study. All subjects 
were women, given that urinary prostaglandins may have 
an extrarenal origin in males. 22 Volunteers with hyperten- 
sive parents were excluded from the study because vascu- 
lar response to sympathetic stimulation has been found to 
be altered in these subjects. 23 The volunteers were con- 
sidered healthy on the basis of medical history, clinical 
examination, blood chemistry, urinalysis, electrocardio- 
gram, and renal ultrasound evaluation. No subject had 
taken either aspirin or any other cyclooxygenase-inhibit- 
ing drug for 15 days before the beginning of the study; no 
subject was taking oral contraceptives. All subjects were 
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Fig. 1. U, Urine sampling; B CI., blood sampling for 131I-labeled 
hippuran and 125I-labeled iothalamate clearances; B Cat & PRA, 
blood sampling for norepinephrine, epinephrine, and PRA; HR & 
BP, HR and blood pressure recording. 
nonsmokers, had body mass indexes of less than 27, and 
had plasma renin activity within the normal range. 
Study protocol The study was performed after the so- 
dium balance had been established by a 5-day diet con- 
taining 108 mmol sodium chloride and 60 to 80 mmol 
potassium. Urinary electrolytes were measured in the 3 
days before the stimulus o as to ensure that they reached 
equilibration (urinary sodium = 70 to 90 mmol/24 hours 
and urinary potassium = 40 to 60 mmol/24 hours). Caf- 
feine- and alcohol-cointaining beverages were not allowed 
on the day of investigation. To achieve a constant urinary 
flow, all subjects were studied under moderate hydration, 
after having drunk 100 ml of tap water every hour on the 
hour from 8 AM until 2 PM on the day of the investigation. 
At noon all subjects had a light meal without any animal 
protein to avoid renal vasodilation. Experiments were 
performed with the subjects in the supine position. A 
catheter was inserted into the urinary bladder to collect 
urinary samples. At the same time, an 18-gauge polytef 
catheter needle with a three-way stopcock was also in- 
serted into the antecubital vein to collect blood samples. 
Each blood sample consisted of a volume of 7 ml of blood, 
which was immediately placed into ice-chilled test tubes 
containing EDTA, 10 mmol/L final concentration. A 
0.95% NaC1 solution was continuously intravenously in- 
fused at a rate of 1.6 ml/min to compensate for plasma 
volume reduction after repeated blood sampling. Soon 
after catheterization f the urinary bladder, two radioiso- 
topes were injected subcutaneously (iodine 125-labeled 
iothalamate, 40 ~Ci, and iodine 131-labeled hippuran, 80 
ixCi) for the measurement of renal clearances. A 40- 
minute equilibration period was needed to achieve con- 
stant plasma radioactivity; only after this time had elapsed 
did the experiment begin. The study consisted of four 
successive 30-minute xperimental periods: baseline de- 
termination, mental stress, and two recovery periods (Fig. 
1). Blood pressure and HR were measured every 10 min- 
utes during baseline and the two recovery periods and 
every 2 minutes during the mental stress period. The 
blood samples for the determination of the cat- 
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Fig. 2. Effects of mental stress on blood pressure and HR (n = 
8). Cross-hatch area indicates values ignificantly different from 
baseline (p < 0.001 for each curve, Duncan test, ANOVA). 
echolamines (norepinephrine and epinephrine) and PRA 
were drawn in the middle of the mental stress period (when 
the expected arousal reaction should have reached its max- 
imum) and in the middle of both the baseline and recovery 
periods. Blood samples for renal clearance determinations 
were drawn at the beginning and at the end of every exper- 
imental period. The 30-minute urinary samples for urinary 
autacoids, renal clearance, and chemical determinations 
were collected uring each experimental period through the 
urinary bladder catheter. 
Preliminary experiments. A preliminary 2-hour experi- 
ment in 5 healthy subjects was devoted to verifying the 
stability and the reproducibility of the measurement of 
ERPF, GFR, blood pressure, and HR. In this preliminary 
study, all conditions were the same as in the experimental 
study except that mental stress was not applied. In this study, 
blood pressure, HR, ERPF, and GFR were all steady. 
Mental stress. Mental stress was induced via the Fair 
Culture Test, a multiple-choice image questionnaire. This 
test was chosen over other forms of psychologic stimuli given 
that it does not require any degree of cultural background, 
such as the solving of arithmetic problems or the reading of 
a text. Indeed, the Fair Culture Test can be administered at
any age, without any regard to scholastic level. 24 The test is 
made up of 50 questions, ubdivided into four sets; each set 
is preceded by a fldl explanation and a preliminary test. To 
elicit a maximal anxiety reaction, the time given for answer- 
ing all questions i carefully controlled. This is a fundamental 
feature of the stimulus, given that time dependence is known 
to elicit significant and increasing anxiety whenever an intel- 
lectual performance is urged. All aspects of the testing had to 
be completed within 30 minutes, according to the study 
protocol. 
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Systemic hemodynamic parameters. Arm blood pres- 
sure was measured by using a sphygmomanometer; he
first Korotkoff sound was taken as an index of systolic 
blood pressure, and the fifth was taken as an index of 
diastolic blood pressure. Mean blood pressure was ob- 
tained by adding one third of the pulse pressure to the 
value of the diastolic pressureY HR was monitored by 
electrocardiogram recording. 
Renal hemodynamic parameters. ERPF and GFR were 
measured according to the methods described by Adefuin et 
al. 26 and Ram. 27 The only variation in methods consisted in 
not calculating the mean plasmatic radioactive concentration 
between the consecutive sampling points but instead making 
calculations with a trend of the plasma curve within each 
sampling interval. In our study, ERPF and GFR data were 
analyzed by fitting a monoexponential curve onto the exper- 
imental data. Within this framework, the mean plasmatic 
radioactive concentration within each interval was calculated 
as the ratio between the integral of the fitted curve within the 
time boundaries of the interval of interest and the length of 
the interval. The fitting procedure was derived from the 
iterative Nelder-Mead simplex search algorithm 28 (Matlab 
software package; Mathworks, Inc., Natick, Mass; PC 80846, 
Windows 3.11 operating system). The values were normal- 
ized to a body surface area of 1.73 m 2. The lzSI-labeled 
iothalamate and 131I-labeled hippuran concentrations were 
measured in 3 ml of plasma and urine with a gamma-ray, 
well-counter spectrometer (COBRA HP; Packard Instru- 
ment Co., Downers Grove, Ill.). In this frame, the detected 
counts on the 131I energy window were as low as 2 orders of 
magnitude with respect to the measured counts on the lZSI 
energy window. Because of this negligible ratio, the spec- 
trometer standard cross-calibration procedure for depleting 
the residual influence of the 131I source on the 125I energy 
window was adopted. The filtration fraction was calculated 
as the ratio of GFR to ERPF. Renal vascnlar resistance was 
calculated by the conventional formula MBP/RBF, where 
MBP equals mean blood pressure and RBF equals renal 
blood flow, and was converted from mm Hg/L/min into 
dyne/sec/cm-S by multiplying by 80. Renal blood flow was 
obtained by using the conventional formula ERPF/(1 - 
hematocrit). 
Urinary prostaglandin assay. PGE2, PGF2~ , 6-keto 
PGF~=, and TXB 2 were measured in urine because they 
reflect the renal synthesis of these substances, e9 Immedi- 
ately after collection the urine was frozen and stored at 
-20 ° C until extraction and purification procedures could 
be performed. Urinary samples were extracted by using an 
organic solvent and then purified by chromatography in a 
silicic acid column according to the method of Jaffe et 
al. 3° Renal eicosanoids were measured by radioimmuno- 
assay according to the method described by Ciabattoni et 
al. 3~ Professor Carlo Patrono, Istituto di Farmacologia, 
Universita' di Chieti, Italy, provided the antibodies to 
PGE 2 and PGF2~ , which were obtained from guinea pigs. 
Professor Bernard Peskar, Lehrstuhl fur Pharmakologie 
und Toxicologie, Ruhr-Universitfit, Bochum, Germany, 
provided the antibody to 6-keto-PGF~=, which was ob- 
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Tab le  I. Ef fects o f  menta l  stress on  p lasma catecho lamines  and  p lasma ren in  ac t iv i ty  (n = 8) 
Baseline Mental stress Recovery I Recovery II 
(30 rain) (30 min) (30 min) (30 min) 
ANOVA for the 
whole curve 
F p 
NE (pg/ml) 
Epi (pg/ml) 
PRA (ng/ml/hr) 
299.0 __+ 191.2 317.5 ± 197.7 
[ _ _ ,  J 
[ ] 
261.2 -+ 147.5 196.5 ± 114.1 
38.7 -+ 8.7 44.0 ± 6.2 33.0 -+ 6.3 
1.62 _+ 0,30 1.60 _+ 1.00 1.07 _+ 0.70 
[ r I 
t | 
6.66 0.01 
J 
30.5 ± 5,7 2,9 ns 
1,13 -+ 0,80 5.96 0.01 
NE, norepinephrine; Epi, epinephrine. 
*p < 0.05 versus baseline, Duncan, ANOVA. 
1-P < 0.01 versus baseline, Duncan, ANOVA. 
Tab le  II. Ef fects o f  menta l  stress on  rena l  hemodynamics  (n = 8) 
Baseline Mental stress 
(30 min) (30 min) 
ANOVA for the 
whole curve Recovery I Recovery II 
(30 min) (30 min) F p 
ERPF (ml/min/1.73 m 2) 
GFR (ml/min/1.73 m 2) 
FF (%) 
RVR (dyne/sec/cm-5/1.73 m 2) 
503.7 ± 63.0 395.0 ± 113.0 
[ _ _ * _ _ 1  
116.3 -+ 20.0 112.2 _+ 27.0 
23.0 ± 4.0 30.0 ± 6.0 
I 1---  I 
t 1 
8100 + 1500 11000 ± 3900 
I $ I 
462,3 ± 60.2 450.1 _+ 50.9 3.60 0.03 
129.8 -+ 27.3 116.0 ± 25.7 1.03 ns 
28.0 _+ 7.0 23.0 ± 5.0 3.53 0.03 
J 
8300 + 2100 8400 ± 2300 8.50 0.0001 
RVR, Renal vascular esistance. 
*p < 0.05 versus baseline, Duncan, ANOVA. 
tP < 0.02 versus baseline, Duncan, ANOVA. 
qtp < 0.001 versus baseline, Duncan, ANOVA. 
tained from rabbits. The antibody to TXB 2 obtained from 
rabbits was provided by Professor Luciano Caprino, Istituto 
di Igiene, Universit~t Cattolica del Sacro Cuore, Rome, Italy. 
The sensitivity and cross-reactivifies of the antibodies have 
already been described elsewhere. 31-33 The average calcu- 
lated recovery was 53% -- 27% for PGE2, 58% ± 15% for 
PGF2~, 56% -+ 11% for 6-keto-PGFl~, and 60% -- 10% for 
q)O32. The intra-assay and interassay coefficients of varia- 
tion were 9% and 10%, respectively. 
Endothelin assay. The urinary immunoreactive endo- 
thelin was measured by radioimmunoassay with a com- 
mercially available kit (Endothelin 1/2 RIA system; Bio- 
medica, Vienna, Austria), after having been extracted 
with Cls SEP-Pack cartridges (Waters-Millipore) accord- 
ing to the method described by Ando et al.34 Because of 
coextraction of all three isoforms of endothelin and be- 
cause of the cross-reactivity of the antibody, radioimmu- 
noassay did not discriminate between endothelin-1 and 
endothelin-2 nor between endothelin-1 and endothelin-3. 
Nonetheless, because immunoreactive endothelin-1 has 
been demostrated to be the predominant isoform in the 
human kidney, 3s the substance that we had measured 
mostly reflects endothelin-1. 
The recovery was 110% -+ 7.7% (mean + SD); the 
detection limit was 0.8 fmol/ml, and the precision profile 
showed a coefficient of variation from 25.5% to 6.3% in 
the 2.5 to 131 fmol/ml range. The within-assay precision 
was 8.36%, for a mean value of 127 ± 10.7 fmol/ml. 
eGMP assay. Nitric oxide production by renal vessels was 
evaluted by measuring urinary cGMP, which is known to be 
stimulated by nitric oxide and to mediate nitric oxide action 
in the kidney. 19,21 Urine samples were stored at -20 ° C until 
assay, cGMP was directly measured in defrosted urinary 
samples after dilution in assay buffer, without any prelimi- 
nary extraction. Urinary cGMP was measured by radioim- 
munoassay with a commercially available kit (cGMP-[lzsI] 
assay system RPA 525; Amersham Laboratories, Bucking- 
hamshire, England) with a nonacetylation technique accord- 
ing to the method escribed by Steiner et al. 36 The standard 
curve ranged from 50 to 6400 fmol/tube. 
The values of the urinary substances, measured uring 
all of the experimental periods, were normalized for indi- 
vidual baseline ERPF, which was expressed inml/min/1.73 
m e , as an index of renal mass. 
Plasma renin activity. PRA was determined by radio- 
immunoassay with a commercially available kit (Anglo- 
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Fig. 3. Effects of mental stress on urinary excretion of endothelin 
(UET-1) (n = 8). ERPF is expressed in ml/min/1.73 m z. Rec 1, 
Recovery period I; Rec 11, recovery period II. *p < 0.01 vs 
baseline, Duncan test, ANOVA. Thin lines indicate individual 
data; thick line indicates mean values. 
tensin RIA CT; RADIM, Rome, Italy) with the method 
described by Haber et al.37 
All radioimmunoassays were performed when the ra- 
dioactivity, because of the 125I and 1311 used for clearance, 
had dropped to low enough values in the collected urine 
and plasma so as not to interfere with the radioimmuno- 
assay. This drop was verified by counting periodically the 
radioactive levels in a sample that had been taken from 
each subject and stored for this purpose. To ensure that 
the level of radioactivity was low enough to avoid inter- 
ference, a 3-month period was usually necessary. 
Furthermore, to validate our methods and to rule out any 
possible influence of a residual trace amount of radioactMty, 
we included blank tubes (all reagents except he first anti- 
body) in all standard and sample series for correction of 
standard and sample counts, respectively. We did not find 
any significant differences (p = 0.7) between the blank tubes 
of the standard series and the blank sample tubes. 
Cateeholamine assay. Plasma catecholamines were de- 
termined by electrochemical detection according to the 
method described by Mefford et al. 3s The calculated re- 
covery determined by measuring the final concentration 
of the internal standard was 89 -+ 5.8 for norepinephrine and 
90.2 + 3.1 for epinephrine. In our laboratory the normal 
ranges of plasma norepinephrine and epinephrine concen- 
trations are 130 to 400 pg/ml and 25 to 100 pg/ml, respec- 
tively. The limit of detection was 10 pg/ml for norepineph- 
fine and epinephrine. The intra-assay coefficient of variation 
was 4.3% for norepinephrine and 3.1% for epinephrine. The 
interassay coefficient of variation was 7.9% for norepineph- 
fine and 6.5% for epinephrine. The concentration of triti- 
ated norepinephrine was determined by liquid scintillation 
counter after extraction with alumina. 
Urinary eleetrol~tes. Urinary electrolytes were mea- 
sured by using a flame photometer (system 243; Instru- 
mentation Laboratory, Lexington, Mass.). 
Statistical analysis. All results have been presented as 
mean + SD. One-way ANOVA and Duncan's test were used 
30 
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Fig. 4. Effects of mental stress on UPGE z (n = 8). ERPF is 
expressed in ml/min/1.73 m 2. Rec 1, Recovery period I; Rec 11, 
recovery period II. *p < 0.01, **p < 0.001 vs baseline, Duncan 
test, ANOVA. Thin lines indicate individual data; thick line indi- 
cates mean values. 
to study the effects induced by mental stress on all parame- 
ters. Linear regression analysis was performed by the least 
square method. The level of probability was set at 0.05. 
RESULTS 
Mental  stress induced significant changes in blood 
pressure and HR that were l imited to the period of 
administration of the stimulus (Fig. 2). Systolic 
blood pressure increased f rom a baseline value of 
114.4 + 14.0 mm Hg to a peak of 134.2 _+ 17.2 mm 
Hg (+17%,  p < 0.001); diastolic blood pressure 
increased f rom 76.0 _+ 7.0 mm Hg to 98.0 _+ 0.3 mm 
Hg (+28%,  p < 0.001), and HR increased f rom 
74.0 +_ 13.0 beats/min to 86.9 --- 14.0 beats/min 
(+17%,p  < 0.001) (Fig. 2). 
Plasma norepinephrine increased slightly but signif- 
icantly during mental stress (317.5 _+ 197.7 pg/ml, vs a 
baseline value of 299 _+ 191.2 pg/ml, p < 0.05) and 
then dropped below baseline values, reaching a mini- 
mum value during the second recovery period 
(196.5 _+ 114.1 pg/ml, p < 0.01 vs baseline) (Table I). 
Plasma epinephrine did not significantly change dur- 
ing the entire study period. Plasma renin activity did 
not change during mental stress but showed a slight- 
though-significant decrease during the recovery peri- 
ods (1.07 _+ 0.7 ng/ml/hr during the first recovery 
period and 1.13 _+ 0.7 ng/ml/hr during the second recov- 
ery period, vs 1.62 + 0.3 ng/ml/hr during baseline, p < 
0.01; p < 0.01 with Duncan ANOVA) (Table I). 
Menta l  stress was also associated with re levant 
changes in renal  hemodynamics .  With the excep- 
t ion of GFR,  all of  the var iables were modi f ied as 
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Tab le  III. Effects of  menta l  stress on urinary vo lume and  sodium excret ion (n = 8) 
ANOVA for the 
whole curve Baseline Mental stress Recovery I Recovery II 
(30 min) (30 min) (30 rain) (30 min) F p 
UV (ml/30 min) 137.1 + 100.8 63.7 _+ 37.0 71.8 + 55.6 
UNa + (mmol/30 min) 14.4 _+ 11.7 11.2 _+ 2,3 7,2 _+ 3.2 
FENa (%) 14.4 + 16.6 4.7 _+ 3.8 2.9 +_ 2.1 
[ __*  __1  
[ 1- J 
[ . 
58.0 _+ 37.1 1.13 ns 
10.4 + 3.4 1.76 ns 
4.0 -+ 3.3 2.60 ns 
UV, Urinary volume; UNa +, urinary sodium; FENa, fractional excretion of sodium. 
*p < 0,05 versus baseline, Duncan, ANOVA. 
tP < 0.02 versus baseline, Duncan, ANOVA. 
Tab le  IV. Effects of  menta l  stress on urinary autaco ids  (n = 8) 
ANOVA for the 
whole curve Baseline Mental stress Recovery I Recovery II 
(30 min) (30 min) (30 rain) (30 min) F p 
6-keto-PGF 1 ~ (pg/ERPF) 12.0 
[ - -  _ _  
[ 
L 
PGF2= (pg/ERPF) 42.0 
TXB2 (pg/ERPF) 7.2 
6-keto-PGF1JTXB 2 ratio 1.8 
L 
L 
PGE2/PGF2, ~ ratio 0.13 
I 
L 
cGMP (pg/ERPF) 40.4 
[ - -  _ _  
__+ 0.1 15.0 __+ 6.0 17.0 __+ 8.0 
* I 
. J 
_+ 14.0 58.0 -+ 18.0 60.0 _+ 14.0 
_+ 2,8 15.0 + 9.0 11.9 _+ 9.0 
-+ 0.4 1.6 -+ 0.3 3.4 _+ 1.9 
. J 
-+ 0.06 0.19 _+ 0.10 0.35 -+ 0.20 
1- I 
t 
_+ 21.4 71.8 -+ 39.9 36.8 + 16.1 
* I 
15.0 _+ 4.0 6.71 0.001 
I 
49.0 + 14.0 1.65 ns 
7.0 _+ 4,2 2.11 ns 
5.0 + 1.8 12.70 0.001 
J 
0.43 + 0.09 8.30 0.01 
I 
52.3 _+ 25.7 4.13 0.01 
ERPF is expressed as ml/min/1.73 m 2. 
*p < 0.01 versus baseline, Duncan, ANOVA. 
IP < 0.001 versus baseline, Duncan, ANOVA. 
demonstrated by ANOVA for the whole curve 
(Table II). ERPF decreased significantly during 
mental stress ( -22%,p < 0.05) and then reverted 
to baseline values. The GFR, on the contrary, did 
not vary throughout the four experimental peri- 
ods. A significant increase in filtration fraction 
occurred uring mental stress and the first recov- 
ery period (+30%,p < 0.02, and +22%,p < 0.02, 
vs baseline). Renal vascular esistance increased 
during mental stress (+37%, p < 0.001). 
Although mental stress had minor effects on urinary 
volume, fractional sodium excretion significantly de- 
creased uring the mental stress and recovery periods 
(Table III). Among the urinary autacoids, mental 
stress induced asignificant increase in endothelin (p < 
0.01) and PGE 2 (p < 0.001), as shown by ANOVA for 
the whole curve (Figs. 3 and 4). Urinary endothelin-1 
increased uring mental stress and during the first 
recovery period (p < 0.01 for both) when compared 
with baseline values by using Duncan ANOVA (Fig. 
3). UPGE 2 increased with growing intensity up to the 
second recovery period, when it reached apeak value 
that was four times higher than baseline (Fig. 4). U6- 
keto-PGFl~ increased uring mental stress and the 
two recovery periods (p < 0.01); UPGF2~ and UTXB 2 
did not significantly increase. U6-keto-PGFI~/UTXB 2 
and UPGEz/UPGF2~ ratios increased uring the two 
recovery periods (p < 0.01 andp < 0.001, respectively, 
during both experimental periods) (Table IV). 
cGMP rose only during the stimulus (71.8 _+ 39.9 
pmol/ERPF during mental stress vs 40.4 _+ 21.4 pmol/ 
ERPF; p < 0.05) and subsequently dropped to base- 
line value during the first recovery period (Table IV). 
DISCUSSION 
The mental stress that we used induced a signifi- 
cant and sustained increase in plasma norepineph- 
rine, HR, and both systolic and diastolic blood pres- 
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sure associated with a 20% reduction in ERPF and 
a constant GFR, effects characteristic of those pro- 
duced by activation of the sympathetic nervous ys- 
tem. 1'2 The trend toward water retention that oc- 
curred was associated with a significant decrease in 
fractional sodium excretion. These findings are also 
consistent with increased renal adrenergic activity. 39 
We did not obtain any evidence of systemic activa- 
tion of the renin angiotensin system given that PRA 
did not increase. 
Changes in the renal hormonal profile having dif- 
ferent ime courses were seen in the excretory patterns 
of prostaglandins, endothelin-1, and cGMP. Activa- 
tion of these hormonal systems resulted from the ini- 
tial sympathetic stimulation followed by interactions 
among involved hormones. 3-s For example, increased 
renal sympathetic a tivity enhances endothelin-1 and 
prostaglandin release, chiefly that of PGE2, as its pri- 
mary effects. 4'm Endothelin-1, in turn, can act as an 
additional stimulus to PGE 2 formation) 1 Thus the 
progressive increase in excretion of PGE2 for 60 min- 
utes beyond the cessation of the stimulus of mental 
stress may be attributed tostimulation by endothelin-1 
as well as promotion of renal prostaglandin synthesis 
by the initial increase in renal adrenergic activity. 4 A 
close link between endothelin and PGE 2 has been 
described in rats and dogs after pharmacologic stimu- 
lation. 11'12 The relatively selective involvement of 
PGE 2 is in keeping with the well-defined modulating 
action of this eicosanoid on pressor systems. 4'4° It also 
should be noted that urinary endothelin excretion may 
reflect events eparate from those xpressed by plasma 
endothelin levels, because there is evidence that 
plasma and renal endothelin represent distinct sys- 
tems.34, 41 
The several components of the neurohumoral re- 
sponse to mental stress may have differential effects 
on GFR. For example, PGI 2 and PGE 2 have been 
reported to produce prevalent dilation of the affer- 
ent arteriole, 4°whereas endothelin and angiotensin 
II have more prominent effects on the efferent ar- 
teriole. 3'42 Even if peripheral venous PRA was not 
changed by the stimulation i the present investiga- 
tion, these data cannot rule out a possible role of 
renal tissue angiotensin II in the adaptation to 
stress. Indeed, the decrease in fractional sodium 
excretion during mental stress that was observed in 
our study can support he hypothesis of an increase 
in tissue angiotensin II. In addition, adrenergic stim- 
ulation and reduced renal perfusion are known to 
increase intrarenal angiotensin II production. 3'43 
The present study does not allow assignment of 
weight o these hormonal inputs that presumably con- 
tribute to the regulation of GFR, because this would 
require an experimental preparation that allowed con- 
trol of important variables uch as isolated perfused 
glomeruli. 
We have shown an early increase in the excretion of 
cGMP that reflects the renal production of nitric oxide 
or ANFY '22 Because we did not measure ANF, only 
tentative conclusions can be reached concerning the 
relationship of cGMP to renal nitric oxide production. 
However, under these xperimental conditions of con- 
stant circulating volume, stimulation of ANF is not 
likely. 44 In addition, stress-induced a renergic activa- 
tion probably does not result in ANF production, be- 
cause there is evidence that in the face of increased 
sympathetic stimulation, ANF release is either blunted 
or unchanged. 45'46 
In conclusion, the renal response to adrenergic 
stimulation induced by mental stress is a complex 
phenomenon that involves the interaction of several 
neurohumoral systems. Endothelin participates in 
renal homeostatic mechanisms together with pros- 
taglandins and possibly nitric oxide. Furthermore, 
these factors have different time courses and can be 
expected to influence the biologic activity of each 
other as well as the overall duration of the activity. 
These time relationships indicate the renal vasocon- 
strictive role of endothelin that is modulated by 
renal vasodilatative autoacoids, in particular PGE2. 
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